Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Tuberculosis
How would you approach using pyrazinamide to treat active pulmonary tuberculosis in an East Asian patient with a history of gout, with a uric acid level of 9.5 mg/dl who is not on allopurinol?
Related Questions
What is your preferred method for latent tuberculosis screening prior to outpatient hemodialysis initiation for a patient with new dialysis requirements?
Would you consider using thalidomide for treating HIV-associated tuberculosis-IRIS in adult patients who have poor response or intolerance to corticosteroid therapy?
Under what circumstances would you choose the 1-month 1HP treatment over a 3-4 month regimen for latent TB?
Would you consider adding azithromycin to standard antituberculosis treatment to reduce inflammation and tissue damage in patients with pulmonary tuberculosis?
Do you routinely treat pregnant patients for latent tuberculosis or delay treatment until 2-3 months post-partum?
What is your approach in managing patients with suspected super-infected pancreatic pseudocysts that are not yet mature enough for drainage?
Do you routinely recommend treatment for patients with chronic osteomyelitis of long bones based on radiographic findings alone in the absence of superficial infection or recommend bone biopsy to evaluate for therapy?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
Under what circumstance would you order dalbavancin instead of vancomycin or daptomycin for MRSA endocarditis?
What false positive findings, if any, do you see in patients who have active hepatitis C?
